Speaker Details

Jonathan S Weiss, MD, FAAD

Jonathan S Weiss, MD, FAAD

SESSIONS

F057 Translating Evidence into Practice: Acne Guidelines and Beyond
Mar 9, 2024 1:00 PM - 3:00 PM Room 2

DISCLOSURES

AbbVie – Investigator(Grants/Research Funding), Speaker(Honoraria); Arcutis, Inc. – Consultant(Honoraria), Speaker(Honoraria); ASLAN Pharmaceuticals – Consultant (1099 relationship)(Fees); Bausch Health – Investigator(Grants/Research Funding); Biofrontera – Consultant(Fees), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Cutera, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Dermavant Sciences – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Galderma Laboratories, L.P. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Incyte Corporation – Advisory Board(Honoraria); Leo Pharma Inc – Consultant(Honoraria), Speaker(Honoraria); Mindera – Investigator(Grants/Research Funding); Novartis – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Ortho Dermatologics – Consultant(Honoraria), Speaker(Honoraria); Palvella Therapeutics – Investigator(Grants/Research Funding); Pfizer Inc. – Speaker(Honoraria); Regeneron – Speaker(Honoraria); Sanofi Genzyme – Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Advisory Board(Honoraria), Consultant(Fees); Verrica Pharmaceuticals Inc – Investigator(Grants/Research Funding);